McCarthy Tétrault advised Medicenna Therapeutics Corp. on the matter. On August 11, 2022, Medicenna Therapeutics Corp. closed its previously announced marketed underwritten public offering of units in Canada and in the United States for an...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here